XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,468,911 | -9.2% | 716,303 | +2.3% | 0.01% | 0.0% |
| Q2 2023 | $26,949,423 | +4471.6% | 699,985 | +4149.8% | 0.01% | – |
| Q1 2023 | $589,497 | -90.3% | 16,471 | -91.7% | 0.00% | -100.0% |
| Q1 2022 | $6,074,000 | -33.9% | 198,701 | -32.4% | 0.00% | 0.0% |
| Q4 2021 | $9,187,000 | +5536.2% | 294,100 | +2269.9% | 0.00% | – |
| Q4 2019 | $163,000 | +71.6% | 12,410 | +17.7% | 0.00% | – |
| Q3 2019 | $95,000 | -30.7% | 10,545 | -23.9% | 0.00% | – |
| Q2 2019 | $137,000 | – | 13,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |